Indivior PLC Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly and | Outperform |
16
|
$766.68 | $636.99 | 14.78% | 9 | $690.32B |
| MRK | Merck | Outperform |
2
|
$127.57 | $130.51 | 12.10% | 11 | $323.11B |
| AZN | AstraZeneca PLC | Outperform |
17
|
£120.50 | £165.99 | 35.23% | 16 | £186.80B |
| PFE | Pfizer | Outperform |
2
|
$28.16 | $32.87 | 8.31% | 6 | $159.46B |
| SAN | Sanofi | Outperform |
16
|
91.02€ | 102.80€ | 19.75% | 9 | 113.65€B |
| ARGX | argenx | Outperform |
4
|
363.40€ | 531.81€ | 20.53% | 10 | 21.58€B |
| GMAB | Genmab A/S | Outperform |
16
|
kr2.00k | kr2.71k | 31.74% | 14 | kr129.44B |
| TEVA | Teva Pharmaceutical Industries | Outperform |
12
|
$14.06 | $11.59 | 13.80% | 9 | $15.92B |
| VTRS | Viatris Inc | Hold |
8
|
$11.82 | $11.73 | 5.75% | 5 | $13.74B |
| REC | Recordati Industria Chimica e ... | Hold |
18
|
50.35€ | 48.61€ | 2.18% | 1 | 10.30€B |
| ITCI | Intra-Cellular Therapies | Outperform |
10
|
$71.01 | $79.10 | 27.45% | 10 | $7.26B |
| ZEAL | Zealand Pharma A/S | Outperform |
8
|
kr628.00 | kr357.00 | 29.78% | 2 | kr39.42B |
| HIK | Hikma Pharmaceuticals PLC | Outperform |
18
|
£19.60 | £28.11 | 49.03% | 9 | £4.35B |
| ORNBV | Orion Oyj | Hold |
14
|
35.97€ | 42.52€ | 16.76% | 3 | 5.04€B |
| ALK B | ALK-Abelló A/S | Outperform |
13
|
kr152.40 | kr109.25 | 8.27% | 3 | kr32.91B |
| HLUN A | H. Lundbeck A/S | Outperform |
18
|
kr33.54 | kr190.00 | 8.83% | 6 | kr32.86B |
| ALKS | Alkermes | Outperform |
10
|
$24.10 | $33.27 | 32.78% | 3 | $4.06B |
| MOR | MorphoSys | Hold |
6
|
66.90€ | 28.78€ | 1.64% | 3 | 2.49€B |
| 1795 | Lotus Pharmaceutical | Buy |
16
|
NT$300.00 | NT$339.40 | 14.67% | 4 | NT$85.42B |
| AMRX | Amneal Pharmaceuticals | Outperform |
16
|
$6.65 | $6.13 | 20.30% | 1 | $2.09B |
| AMPH | Amphastar Pharmaceuticals | Outperform |
14
|
$42.68 | $69.00 | 45.27% | 0 | $2.09B |
| ALM | Almirall | Outperform |
16
|
8.66€ | 11.39€ | 27.02% | 3 | 1.79€B |
| EVT | Evotec | Outperform |
14
|
9.61€ | 37.33€ | 76.90% | 4 | 1.73€B |
| COPN | Cosmo Pharmaceuticals N.V. | Buy |
12
|
CHF72.50 | CHF76.55 | 29.05% | 0 | CHF1.16B |
| FAE | Faes Farma | Hold |
18
|
3.49€ | 3.90€ | 4.58% | 0 | 1.06€B |
| PHM | Pharma Mar | Outperform |
13
|
31.60€ | 50.20€ | 51.90% | 1 | 536.95€M |
| BDSI | BioDelivery Sciences Internati... | - |
11
|
$5.59 | $10.00 | 16.46% | 0 | $577.05M |
| BSLN | Basilea Pharmaceutica | Outperform |
6
|
CHF40.20 | CHF65.63 | 64.18% | 0 | CHF474.13M |
| AQST | Aquestive Therapeutics | Buy |
0
|
$3.50 | $6.33 | 157.14% | 0 | $298.61M |
| VNDA | Vanda Pharmaceuticals | Outperform |
0
|
$4.84 | $4.25 | 7.64% | 0 | $284.01M |
| DBV | DBV Technologies | Outperform |
5
|
1.20€ | 4.07€ | 233.33% | 1 | 119.69€M |
| MOLN | Molecular Partners | Outperform |
4
|
CHF3.35 | CHF9.50 | 179.10% | 1 | CHF110.77M |
| ORX | Orexo AB (publ) |
6
|
kr19.46 | kr25.50 | 18.19% | 0 | kr569.11M | |
| TTNP | Titan Pharmaceuticals | - |
0
|
$6.80 | $7.00 | -100.00% | 0 | $5.61M |